Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

11.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.4K
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

228
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
228
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

478
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
478
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

1.4K
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.4K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

692
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
692
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

528
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
528

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitiligo and skin cancer risk across racial/ethnic groups: A retrospective propensity score-matched study on 123,179 patients.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Off-label testosterone therapy is associated with higher long-term cardiovascular risk in men.

EBioMedicine·2026
Same author

Psychiatric Risk in Chronic Spontaneous Urticaria: A Retrospective Cohort Study.

Acta dermato-venereologica·2026
Same author

Pyoderma gangrenosum is associated with excess incident major atherothrombotic events.

Atherosclerosis·2026
Same author

Mortality, cardiovascular disease, and cancer in coeliac disease and dermatitis herpetiformis: a matched cohort study.

Lancet regional health. Americas·2026
Same author

Second-Generation H1-Antihistamines Do Not Alter Dementia Risk in Type 2 Inflammatory Diseases: A Target Trial Emulation Using Real-World Data.

The journal of allergy and clinical immunology. In practice·2026

Related Experiment Video

Updated: Jan 28, 2026

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

1.0K

Drug Discovery for Pemphigoid Diseases.

Anika Kasprick1, Katja Bieber1, Ralf J Ludwig1

  • 1Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.

Current Protocols in Pharmacology
|February 21, 2019
PubMed
Summary

Pemphigoid diseases (PDs) are autoimmune skin conditions. New mouse models are crucial for understanding PDs and developing effective treatments for this growing condition.

Keywords:
animal modelscytokinepemphigoid diseasepre-clinical model systemssignalingtherapy

More Related Videos

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response
07:59

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response

Published on: May 31, 2024

2.1K
Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

10.7K

Related Experiment Videos

Last Updated: Jan 28, 2026

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

1.0K
Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response
07:59

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response

Published on: May 31, 2024

2.1K
Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

10.7K

Area of Science:

  • Dermatology
  • Immunology
  • Pathology

Background:

  • Pemphigoid diseases (PDs) are autoimmune bullous disorders targeting skin proteins.
  • Characterized by inflammation, blistering, and scarring, PDs cause significant morbidity.
  • Current treatments are limited by efficacy, adverse events, and frequent relapses.

Purpose of the Study:

  • To describe antibody transfer and immunization-induced mouse models for Pemphigoid diseases research.
  • To highlight the utility of these models in understanding PD pathogenesis.
  • To facilitate the development of novel therapeutic interventions for PDs.

Main Methods:

  • Utilized antibody transfer PD models to study autoantibody-mediated pathology.
  • Employed immunization-induced PD models that closely mimic human disease.
  • Applied these models for translational research in Pemphigoid diseases.

Main Results:

  • PD models provide insights into disease pathogenesis.
  • These models are valuable for testing new therapeutic strategies.
  • Advancements in PD models pave the way for new clinical trials.

Conclusions:

  • Mouse models are essential tools for Pemphigoid diseases research.
  • Improved understanding of PD pathogenesis is emerging from these models.
  • These models are critical for advancing drug discovery and clinical trials for PDs.